For 10 million worldwide patients with Parkinson’s disease, news out of Japan that a large pharmaceutical corporation is seeking approval for a new stem cell-based treatment should be hugely encouraging. Following a successful clinical trial in which seniors between 50 and 59 years of age received injections of induced pluripotent stem cells (iPS) and saw […]
The post Company Seeks Sale and Manufacturing Approval for Successful Stem Cell Parkinson’s Treatment appeared first on Good News Network.
Company Seeks Sale and Manufacturing Approval for Successful Stem Cell Parkinson’s Treatment
